Annual Meeting of the International Primary CNS Lymphoma Collaborative Group (IPCG)

国际原发性中枢神经系统淋巴瘤协作组（IPCG）年会

• 批准号: 10391991
• 负责人: Tracy T Batchelor
• 金额: $ 0.5万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-14 至 2022-10-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10391991
• 关键词: American Society of Hematology; Brain; Central Nervous System Lymphoma; Collaborations; Development; Diagnosis; Diagnostic; Discipline; Disease Management; Extranodal; Eye; Group Meetings; Guidelines; Immunotherapeutic agent; International; Leptomeninges; Local Therapy; Lymphoma; Non-Hodgkin' s Lymphoma; Patients; Peer Review; Publishing; Regimen; Research; Review Literature; Role; Series; Specialist; Spinal Cord; Testing; Therapeutic; Variant; interest; meetings; member; symposium; targeted agent

Project Summary Primary central nervous system lymphoma (PCNSL) is an extranodal variant of non-Hodgkin lymphoma (NHL) that is confined to the brain, spinal cord, leptomeninges and eye. The diagnostic and therapeutic approaches to PCNSL are different from those that are applied to other forms of NHL. The International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) consists of specialists from multiple disciplines dedicated to the study of PCNSL. The IPCG holds an annual scientific conference at the American Society of Hematology meeting in which various research topics related to PCNSL are discussed. Experts on the topic under discussion are selected each year by an executive committee to chair the scientific conference. These meetings have led to multiple collaborative projects that have positively impacted the field and that have been published in the peer reviewed literature. The annual IPCG meeting is a critical forum for generating new ideas and approaches to this unique and rare form of lymphoma. The 2021 conference topic is Primary Vitreoretinal Lymphoma (PVRL): Advances in Diagnostics and Management. PVRL is rare and there are no standard guidelines for management of this disease. The IPCG previously published results from a large series of patients with PVRL (Grimm et al, Ann Oncol 2007). Since then, there has been development in the diagnostics of PVRL and studies demonstrating efficacy of targeted agents. Accordingly, it is of great interest to IPCG members to have a symposium of diagnosis and treatment of PVRL.

项目摘要 原发性中枢神经系统淋巴瘤(PCNSL)是非霍奇金淋巴瘤的结外变异 淋巴瘤(NHL)，局限于大脑、脊髓、软脑膜和眼睛。诊断 治疗PCNSL的方法不同于应用于其他形式的 非霍奇金淋巴瘤。国际初级中枢神经系统淋巴瘤合作小组(IPCG) 由多个学科的专家组成，致力于PCNSL的研究。IPCG认为 在美国血液病学会会议上举行的年度科学会议上，各种 讨论了与PCNSL相关的研究课题。正在讨论的主题的专家被挑选出来 每年由一个执行委员会主持科学会议。这些会议导致了 已对该领域产生积极影响的多个协作项目 发表在同行评议文献中。IPCG年度会议是一个重要的论坛 为这种独特而罕见的淋巴瘤产生新的想法和方法。2021年 会议主题为原发性玻璃体视网膜淋巴瘤(PVRL)：诊断和治疗进展 管理层。PVRL是一种罕见的疾病，目前还没有标准的治疗指南。 IPCG之前发表了一系列PVRL患者的结果(Grimm等人， Ann Oncol2007)。从那时起，PVRL的诊断和研究有了进展 展示靶向制剂的有效性。因此，IPCG成员非常感兴趣的是 召开PVRL诊断与治疗研讨会。